1
|
Ullmann E, Licinio J, Perry SW, White LO, Klein AM, Barthel A, Petrowski K, Stalder T, Oratovski B, von Klitzing K, Bornstein SR, Kirschbaum C. Inherited anxiety-related parent-infant dyads alter LHPA activity. Stress 2019; 22:27-35. [PMID: 30424700 DOI: 10.1080/10253890.2018.1494151] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
Abstract
The pathogenesis of post-traumatic stress disorder (PTSD) is incompletely understood. We hypothesize that disruptions in mother-child relations may be a key contributor to development of PTSD. A normal and healthy separation-individuation process requires adaptations of self- and interactive contingency in both the mother and her child, especially in early childhood development. Anxious mothers are prone to overprotection, which may hinder the individuation process in their children. We examined long-term stress hormones and other stress markers in subjects three generations removed from the Holocaust, to assess the long-term consequences of inherited behavioral and physiological responses to prior stress and trauma. Jewish subjects who recalled overprotective parental behavior had higher hairsteroid-concentrations and dampened limbic-hypothalamic-pituitary-adrenal (LHPA) axis reactivity compared to German and Russian-German subjects with overprotective parents. We suggest that altered LHPA axis activity in maternally overprotected Jewish subjects may indicate a transmitted pathomechanism of "frustrated individuation" resulting from cross-generational anti-Semitic experiences. Thus measurements of hairsteroid-concentrations and parenting practices may have clinical value for diagnosis of PTSD. We propose that this apparent inherited adaptivity of LHPA axis activity could promote higher individual stress resistance, albeit with risk of an allostatic overload.
Collapse
Affiliation(s)
- E Ullmann
- a Department of Medicine , Carl Gustav Carus, Technical University of Dresden , Dresden , Germany
- b Department of Child and Adolescent Psychiatry , Psychotherapy, and Psychosomatics, University of Leipzig , Leipzig , Germany
| | - J Licinio
- c College of Medicine , SUNY Upstate Medical University , New York , NY, USA
| | - S W Perry
- c College of Medicine , SUNY Upstate Medical University , New York , NY, USA
| | - L O White
- b Department of Child and Adolescent Psychiatry , Psychotherapy, and Psychosomatics, University of Leipzig , Leipzig , Germany
| | - A M Klein
- b Department of Child and Adolescent Psychiatry , Psychotherapy, and Psychosomatics, University of Leipzig , Leipzig , Germany
- d International Psychoanalytic University Berlin , Berlin, Germany
| | - A Barthel
- a Department of Medicine , Carl Gustav Carus, Technical University of Dresden , Dresden , Germany
- e Medicover , Bochum , Germany
| | - K Petrowski
- f Department of Psychology , University of Witten/Herdecke , Witten/Herdecke , Germany
| | - T Stalder
- g Department of Psychology , Biopsychology, Technical University of Dresden , Dresden , Germany
- h Department of Developmental Psychology , University of Siegen , Siegen , Germany
| | - B Oratovski
- a Department of Medicine , Carl Gustav Carus, Technical University of Dresden , Dresden , Germany
| | - K von Klitzing
- b Department of Child and Adolescent Psychiatry , Psychotherapy, and Psychosomatics, University of Leipzig , Leipzig , Germany
| | - S R Bornstein
- a Department of Medicine , Carl Gustav Carus, Technical University of Dresden , Dresden , Germany
- i Faculty of Life Sciences & Medicine, Endocrinology and Diabetes , Kings College London , London , UK
| | - C Kirschbaum
- g Department of Psychology , Biopsychology, Technical University of Dresden , Dresden , Germany
| |
Collapse
|
2
|
Tobin CM, Darville JM, Thomson AH, Sweeney G, Wilson JF, MacGowan AP, White LO. Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire. J Antimicrob Chemother 2002; 50:713-8. [PMID: 12407128 DOI: 10.1093/jac/dkf212] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
This study investigated vancomycin therapeutic drug monitoring (TDM) and issues related to patient management. Questionnaires were distributed to 310 participants in the UK National External Quality Assessment Scheme (NEQAS) for Antibiotic Assays. The response rate was 57.4%. The majority (76%) had an 'in-house' assay service based, almost exclusively, in the microbiology department, and a fluorescence polarization immunoassay (FPIA) was used by 97%. Almost half (48.7%) had an assay service available for 24 h/day, 7 days/week and 92.7% expected same-day results. The majority (80%) had issued guidelines for vancomycin use. A 12 hourly initial dosing regimen was used by 89%. Trough assay samples were taken <10 min before the dose by 91.5%. For post-dose assay samples, 44% took a sample at 1 h, 28% at 2 h and the remainder at 'other' times. For trough target ranges, 93% quoted <10 mg/L or 5-10 mg/L. There was no consensus with regard to post-dose assay sample times and 23 ranges were quoted. The majority (74.4%) regarded a trough level of >or=10 mg/L as 'toxic' but 13 concentrations were quoted as toxic post-dose measurements. In conclusion, there was a wide variability and poor consensus with regard to post-dose vancomycin assay sampling times, target ranges and what constituted a toxic level.
Collapse
Affiliation(s)
- C M Tobin
- Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology, Southmead Hospital, North Bristol NHS Trust, Bristol BS10 5NB, UK.
| | | | | | | | | | | | | |
Collapse
|
3
|
Tobin CM, Sunderland J, White LO, MacGowan AP. A simple, isocratic high-performance liquid chromatography assay for linezolid in human serum. J Antimicrob Chemother 2001; 48:605-8. [PMID: 11679548 DOI: 10.1093/jac/48.5.605] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
A rapid high-performance liquid chromatography (HPLC) assay for the detection of linezolid in human serum was developed. The method used a Hypersil 5ODS stationary phase. The mobile phase was 1% ortho-phosphoric acid, 30% methanol, 2 g/L heptane sulphonic acid, pH 5. UV absorbance detection was used (lambda(max) 254 nm). Samples were prepared by mixing with acetonitrile and an injection volume of 20 microL was used. The inter- and intra-day assay reproducibility were assessed. Assay linearity, specificity and accuracy were investigated. The detection limit and recovery of linezolid from serum were determined. In addition, the stability of linezolid, stored under a variety of conditions, was assessed. The retention time of linezolid was c. 6.5 min. The intra- and inter-day reproducibility was good and the assay was linear across the therapeutic range. Serum recovery was c. 100% at all concentrations tested. The detection limit was 0.1 mg/L and the assay was accurate. The assay was specific as there was no significant interference with the linezolid peak. Linezolid was demonstrated to be stable. This rapid assay is ideal for busy clinical laboratories with basic HPLC equipment.
Collapse
Affiliation(s)
- C M Tobin
- Bristol Centre for Antimicrobial Research and Evaluation, Department of Microbiology, Southmead Hospital, Bristol BS10 5NB, UK.
| | | | | | | |
Collapse
|
4
|
Sunderland J, Tobin CM, Hedges AJ, MacGowan AP, White LO. Antimicrobial activity of fluoroquinolone photodegradation products determined by parallel-line bioassay and high performance liquid chromatography. J Antimicrob Chemother 2001; 47:271-5. [PMID: 11222559 DOI: 10.1093/jac/47.3.271] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The fluoroquinolones produce multiple photodegradation products. Little is known about these products, particularly whether any possess antimicrobial activity. To investigate this, we used the parallel-line bioassay to investigate discrepancies in zone of inhibition size in conjunction with high performance liquid chromatography (HPLC) analysis. A continuous flow photochemical reaction unit ('Beam-Boost') was used to partially photodegrade the fluoroquinolones ofloxacin, levofloxacin, ciprofloxacin and moxifloxacin (0.02 mM) by between 15 and 89%, as confirmed by HPLC. The concentration of residual parent fluoroquinolone in each irradiated sample was measured by HPLC and a non-irradiated control solution was prepared at the same concentration. These were compared by parallel-line bioassays using Escherichia coli, Enterobacter cloacae and Klebsiella oxytoca. With ofloxacin and levofloxacin, the zone size for the control solution was significantly less than that of the irradiated solutions, with >15% photodegradation in at least two of the indicator organisms, indicating that the photodegradation products possess antimicrobial activity. No difference was seen with ciprofloxacin at any level of photodegradation with any of the indicator organisms, nor with moxifloxacin at 30 and 54% photodegradation. A significant difference was observed with E. cloacae only, at 83% photodegradation.
Collapse
Affiliation(s)
- J Sunderland
- Bristol Centre for Antimicrobial Research and Evaluation, North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UK.
| | | | | | | | | |
Collapse
|
5
|
White LO, Sunderland J. Laboratory implications of incorrectly taken blood samples for antibiotic assay. J Antimicrob Chemother 2000; 46:1043-4. [PMID: 11102433 DOI: 10.1093/jac/46.6.1043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
6
|
Abstract
How providers of external quality assessment (EQA) programmes relate to and interact with the monitors and watchdog of clinical laboratory performance in the UK is described. With regard to the quality of antibiotic assays, the changes in methodologies and in performance quality between 1971 (when the UK NEQAS for Antibiotic Assays began) and 1999 is reviewed. How improvements in performance and changes of methodology are related is discussed. The findings and conclusions of two experimental pilot EQA distributions (the teicoplanin assay and serum bactericidal test) are also discussed.
Collapse
Affiliation(s)
- L O White
- Bristol Centre for Antimicrobial Research and Evaluation, Department of Medical Microbiology, Southmead Hospital, Bristol BS10 5NB, UK.
| |
Collapse
|
7
|
Harding I, MacGowan AP, White LO, Darley ES, Reed V. Teicoplanin therapy for Staphylococcus aureus septicaemia: relationship between pre-dose serum concentrations and outcome. J Antimicrob Chemother 2000; 45:835-41. [PMID: 10837438 DOI: 10.1093/jac/45.6.835] [Citation(s) in RCA: 100] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Logistic regression analysis was performed on data drawn from a clinical trials database for Staphylococcus aureus septicaemia treated with teicoplanin. Variables analysed were age, body weight, mean pre-dose and post-dose serum teicoplanin concentrations, mean dose (mg or mg/kg body weight) and combination versus monotherapy. Only two variables correlated with clinical outcome at a significance level better than 0.05: age (P = 0.012) and mean pre-dose serum concentration (P = 0.010). The probability of successful treatment declined with age and increased with mean pre-dose serum concentration.
Collapse
Affiliation(s)
- I Harding
- Micron Research Ltd, Upwell PE14 9AR, UK
| | | | | | | | | |
Collapse
|
8
|
Abstract
Antibiotic-free human serum was spiked with known concentrations of liposomal amikacin and assayed on the Abbott TDx System, using polarization fluoroimmuno assay (PFIA) kits from Abbott Laboratories, Oxis and Sigma. Although all three kits gave a linear response, the Abbott and Oxis kits showed very low recovery (<21%) with only the Sigma kit giving near 100% recovery. Heating samples at 56 degrees C for 30 min improved recovery with the Abbott and Oxis kits (75-80% of target value), but decreased recovery with the Sigma kit (85% of target value). The loss of amikacin from liposomal amikacin, as measured using the Sigma kit, was related to both temperature and duration of heating, reaching a maximal loss of 21% after 1 h at 60 degrees C.
Collapse
Affiliation(s)
- A M Lovering
- Bristol Centre for Antimicrobial Research and Evaluation, Southmead Hospital, Westbury on Trym, UK
| | | | | |
Collapse
|
9
|
Tobin CM, Sunderland J, White LO, MacGowan AP. A reverse-phase, isocratic high-performance liquid chromatography assay for levofloxacin. J Antimicrob Chemother 1999; 43:434-5. [PMID: 10223609 DOI: 10.1093/jac/43.3.434] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
|
11
|
Tobin CM, Sunderland J, MacGowan AP, Hedges AJ, White LO. Antimicrobial Activity of Moxifloxacin and Levofloxacin Photodegradation Products. Drugs 1999. [DOI: 10.2165/00003495-199958002-00037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
12
|
Abstract
Clinical laboratory investigations used to aid antimicrobial chemotherapy of serious infection include routine sensitivity testing and, in the case of those drugs with a narrow therapeutic range, routine assays for therapeutic monitoring to assist with dosage individualization. Tests must be of a sufficiently high quality to be clinically useful. Laboratories ensure quality through standard operating procedures, internal quality control procedures, and participation in external quality assessment (EQA) programs. This article demonstrates how EQA returns to the United Kingdom National External Quality Assessment Scheme for Antibiotic Assays and the activity of the United Kingdom National Quality Assurance Advisory Panel showed marked improvement in the technical quality of assays as exemplified by gentamicin assays. The article also highlights additional quality concerns not subject to EQA.
Collapse
Affiliation(s)
- L O White
- United Kingdom National External Quality Assessment Scheme for Antibiotic Assays, Bristol Centre for Antimicrobial Research and Evaluation, Southmead Hospital
| |
Collapse
|
13
|
Tobin CM, Sunderland J, White LO, MacGowan AP, Reeves DS. An isocratic high performance liquid chromatography (HPLC) assay for moxifloxacin, a new 8-methoxyquinolone. J Antimicrob Chemother 1998; 42:278-9. [PMID: 9738857 DOI: 10.1093/jac/42.2.278] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Abstract
PURPOSE To determine the half-life of intracameral gentamicin administered during phacoemulsification. SETTING Southampton Eye Unit, Southampton General Hospital, England. METHODS Thirty-one patients having scleral tunnel phacoemulsification were given intracameral gentamicin in the irrigation fluid. Samples of fluid were taken from the anterior chamber at the end of the operation and at various times postoperatively. The concentration of gentamicin in the samples was determined by fluorescence polarization immunoassay and the half-life calculated for a single compartment model using a peeling algorithm. RESULTS The concentration of gentamicin in the anterior chamber after phacoemulsification decreased by half every 51 minutes (95% confidence interval, 42 to 66 minutes). CONCLUSION Intracameral gentamicin was cleared from the anterior chamber after phacoemulsification at a rate that prevents the maintainance of the bactericidal levels required for reliable antibiotic prophylaxis.
Collapse
Affiliation(s)
- O J Lehmann
- Southampton Eye Unit, Southampton General Hospital, England
| | | | | | | | | |
Collapse
|
15
|
Jones EM, McMullin CM, Hedges AJ, Lovering AM, White LO, Reeves DS, MacGowan AP. The pharmacokinetics of intravenous ciprofloxacin 400 mg 12 hourly in patients with severe sepsis: the effect of renal function and intra-abdominal disease. J Antimicrob Chemother 1997; 40:121-4. [PMID: 9249215 DOI: 10.1093/jac/40.1.121] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
Serum concentrations of ciprofloxacin were reviewed in 22 patients given ciprofloxacin 400 mg intravenously 12 hourly for severe infection. No dosage modifications were made in patients with renal impairment. Patients who had either bowel or liver pathology in addition to renal failure had significantly higher serum concentrations than all other patients. Dosage reduction of ciprofloxacin in patients with severe sepsis and impaired renal function is not required unless they have co-existent intra-abdominal disease.
Collapse
Affiliation(s)
- E M Jones
- Bristol Centre for Antimicrobial Research and Evaluation, Southmead Health Services NHS Trust and the University of Bristol, Southmead Hospital, Westbury-on-Trym, UK.
| | | | | | | | | | | | | |
Collapse
|
16
|
McMullin CM, Brown NM, Brown IM, Tomson CR, White LO, Reeves DS, MacGown AP. The pharmacokinetics of once-daily oral 400 mg ofloxacin in patients with peritonitis complicating continuous ambulatory peritoneal dialysis. J Antimicrob Chemother 1997; 39:829-31. [PMID: 9222057 DOI: 10.1093/jac/39.6.829] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
Seven patients with end-stage renal disease requiring support by continuous ambulatory peritoneal dialysis received once-daily 400 mg oral ofloxacin for 7 days for the treatment of bacterial peritonitis. Serum and peritoneal dialysis fluid (PDF) were collected for assay throughout the course of the study and for 5 days thereafter. Ofloxacin, desmethyl ofloxacin and ofloxacin-N-oxide accumulated over the course of therapy and could still be detected in serum and PDF 5 days after the end of therapy. The mean elimination half-life of ofloxacin in serum was 32 +/- 7 h, desmethyl ofloxacin 45 +/- 26 h and for ofloxacin-N-oxide 44 +/- 15 h. The total mean recovery of ofloxacin and its metabolites from the PDF was 15.4%. This regimen results in serum and PDF concentrations likely to be effective for the treatment of infection for at least 10 days.
Collapse
Affiliation(s)
- C M McMullin
- Bristol Centre for Antimicrobial Research and Evaluation, Southmead Health Services NHS Trust and University of Bristol, Department of Medical Microbiology, UK.
| | | | | | | | | | | | | |
Collapse
|
17
|
White LO, Holt HA, Reeves DS, MacGowan AP. Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.net. J Antimicrob Chemother 1997; 39:355-61. [PMID: 9096185 DOI: 10.1093/jac/39.3.355] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Abstract
The Innofluor fluorescence polarization immunoassay (FPIA) kits for gentamicin, tobramycin, amikacin and vancomycin were evaluated on an Abbott TDX analyser. Intra-assay reproducibility was excellent with a coefficient of variation of <3% for all analytes. The coefficient of variation for inter-assay reproducibility was usually <5%. Assay linearity was good and standard curve stability was seen with kits of the same batch for at least 32 days. Using clinical samples, the results obtained with the Innofluor FPIA reagents correlated well with those obtained using Abbott FPIA reagents, but Innofluor gentamicin and amikacin results were slightly higher than Abbott results (P < 0.001). Results of UK NEQAS returns showed acceptable accuracy for the Innofluor kits, but mean Innofluor gentamicin returns were 4% higher (P = 0.001) and mean vancomycin returns were 5% lower (P = 0.001) than overall mean returns. Innofluor and Abbott vancomycin assay reagents showed similar cross-reactivity to degraded vancomycin.
Collapse
Affiliation(s)
- L O White
- Department of Medical Microbiology, Southmead Health Services NHS Trust, Bristol, UK
| | | | | | | |
Collapse
|
18
|
Lovering AM, White LO, MacGowan AP, Reeves DS. The elution and binding characteristics of rifampicin for three commercially available protein-sealed vascular grafts. J Antimicrob Chemother 1996; 38:599-604. [PMID: 8937955 DOI: 10.1093/jac/38.4.599] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Rifampicin was absorbed onto gelatin-sealed (Gelsoft and Unigraft) or collagen-sealed (Hemashield) vascular grafts by soaking for 15 min in a 1000 mg/L solution. Bound drug was then eluted from the grafts by incubation in phosphate buffered saline (PBS) at 37 degrees C and at timed intervals the concentration of rifampicin remaining in the grafts was determined. Although all three grafts contained high concentrations of rifampicin immediately after absorption of drug, rifampicin concentrations rapidly fell during elution with PBS to approximately 1.25 mg/kg of graft after 5 h incubation in PBS, indicating that most of the rifampicin absorbed to the grafts was only loosely bound. However, once this loosely bound fraction had been removed there was a much slower elution of the remaining rifampicin from the grafts, suggesting a second and much more tightly bound fraction. The tightly bound fraction eluted with an apparent half-life of 47-76 h, depending on the graft, and extrapolation back to time zero from this phase suggests that only a very small amount of the rifampicin is tightly bound to the graft after initial soaking (0.6-1.3 mg/kg).
Collapse
Affiliation(s)
- A M Lovering
- Bristol Centre for Antimicrobial Research and Evaluation, Department of Medical Microbiology, Southmead Hospital, Westbury on Trym, UK
| | | | | | | |
Collapse
|
19
|
McMullin CM, Kirk B, Sunderland J, White LO, Reeves DS, MacGowan AP. A simple high performance liquid chromatography (HPLC) assay for aciclovir and ganciclovir in serum. J Antimicrob Chemother 1996; 38:739-40. [PMID: 8937970 DOI: 10.1093/jac/38.4.739] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
|
20
|
White LO, McMullin C, Davis AJ, MacGowan AP, Harding I, Reeves DS. The quality of clinical serum teicoplanin assays: an experimental European EQA distribution. J Antimicrob Chemother 1996; 38:701-6. [PMID: 8937964 DOI: 10.1093/jac/38.4.701] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
Two sets of six samples of human serum spiked with predetermined concentrations of teicoplanin were circulated, 6 months apart, to 22 European laboratories for the purposes of external quality assessment (EQA). The laboratories returned assay results using either bioassay, high-performance liquid chromatography (HPLC) or fluorescence polarization immunoassay (FPIA). FPIA was the most popular method and performance was generally satisfactory. Some laboratories using HPLC or microbiological assay performed satisfactorily but others did not. Only seven laboratories (32%) showed consistently satisfactory performance. There appears to be a need for continuing EQA of clinical teicoplanin assays.
Collapse
Affiliation(s)
- L O White
- UK NEQAS for Antibiotic Assays, Southmead Hospital Bristol, UK
| | | | | | | | | | | |
Collapse
|
21
|
Bethell DB, Day NP, Dung NM, McMullin C, Loan HT, Tam DT, Minh LT, Linh NT, Dung NQ, Vinh H, MacGowan AP, White LO, White NJ. Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob Agents Chemother 1996; 40:2167-72. [PMID: 8878600 PMCID: PMC163492 DOI: 10.1128/aac.40.9.2167] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023] Open
Abstract
The pharmacokinetics of oral and intravenous ofloxacin (7.5 mg.kg of body weight-1 given over 30 min) were studied in an open crossover study of 17 Vietnamese children, aged between 5 and 14 years, with acute uncomplicated typhoid fever. Following oral administration, the median (95% confidence interval [CI]) time to peak concentration of ofloxacin in serum (Cmax) was 1.7 h (1.4 to 1.9 h) and the mean (95% CI) Cmax was 5.5 mg.liter-1 (4.7 to 6.3 mg.liter-1) compared with a Cmax of 8.7 mg.liter-1 (7.6 to 9.7 mg.liter-1) following the intravenous infusion. The median (95% CI) total apparent volume of distribution following the first intravenous dose, 1.35 liter.kg-1 (1.17 to 1.73 liter.kg-1), was significantly larger than that following the second dose, 0.99 liter.kg-1 (0.86 to 1.17 liter.kg-1; P < 0.0005), although the estimates for systemic clearance were similar: 0.255 liter.kg-1 h-1 (0.147 to 0.325 liter.kg-1 h-1) compared with 0.172 liter.kg-1 h-1 (0.127 to 0.292 liter.kg-1 h-1; P = 0.14). The mean residence times (95% CI) following intravenous and oral administration were similar: 5.24 h (4.84 to 6.58 h) and 6.24 h (5.32 to 7.85 h), respectively. The mean (95% CI) oral bioavailability was 91% (74 to 109%). The peak concentrations in serum were 10 to 100 times higher than the maximum MICs for ofloxacin against multidrug-resistant Salmonella typhi isolated in this area. Although the systemic clearance values were higher than those reported previously for adults, these data overall suggest that weight-or area-adjusted dose regimens for the treatment of typhoid in older children should be the same as those for adults.
Collapse
Affiliation(s)
- D B Bethell
- Centre for Tropical Diseases, Ho Chi Minh City, Vietnam
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
McMullin CM, White LO, Reeves DS, Lovering AM, Lewis RJ. Photodegradation of fluoroquinolones using a continuous-flow photochemical reaction unit. J Antimicrob Chemother 1996; 37:392-4. [PMID: 8707754 DOI: 10.1093/jac/37.2.392] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
|
23
|
|
24
|
|
25
|
Lovering AM, Vickery CJ, Watkin DS, Leaper D, McMullin CM, White LO, Reeves DS, MacGowan AP. The pharmacokinetics of meropenem in surgical patients with moderate or severe infections. J Antimicrob Chemother 1995; 36:165-72. [PMID: 8537263 DOI: 10.1093/jac/36.1.165] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023] Open
Abstract
The pharmacokinetics of meropenem were studied in a group of 11 surgical patients (four male, seven female; mean age 63 years; mean weight 72 kg) all of whom had moderate or severe infection and who received a mean dose of 14.5 mg/kg +/- 2.7 meropenem 8-hourly iv for a minimum of 4 days. Venous blood samples were collected at timed intervals after the first dose on day 1 and the second dose on the fourth or fifth day of therapy. Serum meropenem concentrations were assayed by HPLC and fitted to a two compartment pharmacokinetic model. The mean pharmacokinetic parameters (+/- standard deviation) on day 1 were T1/2 84.6 +/- 24.1 min, Vdss 0.22 +/- 0.06 L/kg, AUC 6028 +/- 1983.2 mg.min/L, Cltot 188 +/- 67 mL/min and MRT 89.1 +/- 67.8 min. On the fourth or fifth days of therapy the values were T1/2 79.9 +/- 18.2 min, Vdss 0.17 +/- 0.8 L/kg, AUC 6000.7 +/- 2417 mg.min/L, Cltot 190 +/- 60 mL/min and MRT 67.8 +/- 30.4 min. Although the T1/2, Vdss and MRT decreased from day 1 to day 4 or 5 these changes were not statistically significant (Student's t-test, P > 0.05). Total clearance of meropenem was linearly related to creatinine clearance or patient age on the first day of therapy. Although the T1/2 and MRT were longer and the Cltot lower than those reported for young healthy volunteers, they were similar to those found in elderly volunteers.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- A M Lovering
- Department of Medical Microbiology, Southmead Health Services NHS Trust, Westbury-on-Trym, Bristol, UK
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Reeves DS, MacGowan AP, Holt HA, Lovering AM, Warnock DW, White LO. Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993. J Antimicrob Chemother 1995; 35:213-26. [PMID: 7768771 DOI: 10.1093/jac/35.1.213] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Affiliation(s)
- D S Reeves
- Department of Medical Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | | | | | |
Collapse
|
27
|
Holt HA, White LO, Bedford KA, Bowker KE, Reeves DS, MacGowan AP. An evaluation of three new immunoassays for determination of serum gentamicin concentrations. J Antimicrob Chemother 1994; 34:747-54. [PMID: 7706170 DOI: 10.1093/jac/34.5.747] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Three new immunoassays for determination of serum gentamicin concentration were assessed: a latex agglutination assay (Technicon), an enzyme immunoassay (EMIT 2000) and a multi-layer thin-film immunoassay (Opus). All three were easy to use, had good within- and between-assay reproducibility, good reliability and acceptable linearity. The standard curve stability was shortest with the latex agglutination assay and longest with the thin-film. The thin-film assay calibrators gave approximately double the expected concentration when assayed by polarisation fluoroimmunoassay but this did not effect the assay's performance. When compared with the polarisation fluoroimmunoassay results of patient samples, all three methods gave an excellent correlation. The technical aspects of these three methods make them acceptable for clinical use.
Collapse
Affiliation(s)
- H A Holt
- Department of Medical Microbiology, Southmead Health Services NHS Trust, Westbury-on-Trym, Bristol, UK
| | | | | | | | | | | |
Collapse
|
28
|
MacGowan AP, Bedford KA, Blundell E, Brown NM, Habib F, Hows J, Kirkpatrick B, Korner RJ, Slade RR, White LO. The pharmacokinetics of once daily gentamicin in neutropenic adults with haematological malignancy. J Antimicrob Chemother 1994; 34:809-12. [PMID: 7706178 DOI: 10.1093/jac/34.5.809] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023] Open
Abstract
Seven febrile neutropenic adults with normal renal function were treated with intravenous gentamicin 4.5 mg/kg once a day in combination with azlocillin. Gentamicin serum concentrations 1, 2, 4, 8, and 24 h after a 30 min infusion were 10.9 +/- 0.6, 7.1 +/- 0.4, 4.2 +/- 0.2, 1.8 +/- 0.1 and 0.16 +/- 0.003 mg/L respectively. The pharmacokinetics were best described by a triphasic plot including a distribution phase (about 1/2 h) and two elimination phases, an early and late.
Collapse
Affiliation(s)
- A P MacGowan
- Department of Medical Microbiology, Southmead Health Services NHS Trust, Westbury-on-Trym, Bristol, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
29
|
McMullin CM, White LO, MacGowan AP, Holt HA, Lovering AM, Reeves DS. Assay of serum teicoplanin concentrations in clinical specimens: a comparison of isocratic high performance liquid chromatography with polarisation fluoroimmunoassay and bioassay. J Antimicrob Chemother 1994; 34:425-9. [PMID: 7829418 DOI: 10.1093/jac/34.3.425] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
Affiliation(s)
- C M McMullin
- Department of Medical Microbiology, Southmead Health Services NHS Trust, Bristol, UK
| | | | | | | | | | | |
Collapse
|
30
|
Körner RJ, McMullin CM, Bowker KA, White LO, Reeves DS, MacGowan AP. The serum concentrations of desmethyl ofloxacin and ofloxacin N-oxide in seriously ill patients and their possible contributions to the antibacterial activity of ofloxacin. J Antimicrob Chemother 1994; 34:300-3. [PMID: 7814297 DOI: 10.1093/jac/34.2.300] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023] Open
|
31
|
White LO, MacGowan AP, Lovering AM, Holt HA, Reeves DS, Ryder D. Assay of low trough serum gentamicin concentrations by fluorescence polarization immunoassay. J Antimicrob Chemother 1994; 33:1068-70. [PMID: 8089059 DOI: 10.1093/jac/33.5.1068] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
|
32
|
|
33
|
MacGowan AP, White LO, Brown NM, Lovering AM, McMullin CM, Reeves DS. Serum ciprofloxacin concentrations in patients with severe sepsis being treated with ciprofloxacin 200 mg i.v. bd irrespective of renal function. J Antimicrob Chemother 1994; 33:1051-4. [PMID: 8089053 DOI: 10.1093/jac/33.5.1051] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Affiliation(s)
- A P MacGowan
- Department of Medical Microbiology, Southmead Health Services NHS Trust, Bristol, UK
| | | | | | | | | | | |
Collapse
|
34
|
MacGowan AP, White LO, Brown EM, Reeves DS. Penetration of cefixime into the cerebrospinal fluid of patients with non-inflamed meninges. J Antimicrob Chemother 1993; 32:783-4. [PMID: 8125848 DOI: 10.1093/jac/32.5.783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
|
35
|
Brown EM, Finch RG, White LO. Preface. J Antimicrob Chemother 1993. [DOI: 10.1093/jac/32.suppl_b.iii] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
36
|
Brown NM, White LO, Blundell EL, Chown SR, Slade RR, MacGowan AP, Reeves DS. Absorption of oral ofloxacin after cytotoxic chemotherapy for haematological malignancy. J Antimicrob Chemother 1993; 32:117-22. [PMID: 8226402 DOI: 10.1093/jac/32.1.117] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023] Open
Abstract
Ten patients with newly diagnosed haematological malignancy were given ofloxacin, 400 mg daily orally, for antibacterial prophylaxis during neutropenia. Before cytotoxic chemotherapy was given, and on three occasions between days 2-3, 5-7 and 8-10 afterwards, blood samples were taken before and 1, 2, 3, 4, 6 and 10 h after administration of ofloxacin. Serum ofloxacin concentrations were measured by HPLC. Mean (range) pharmacokinetic parameters before chemotherapy were: Cmax, 6.1 (2.7-9.1) mg/L; AUC0-2, 7.5 (1.9-11.6) mg.h/L. On days 2-3 post-chemotherapy the values were reduced to: Cmax, 5.0 (3.6-7.3) mg/L; AUC0-2, 5.8 (1.9-7.8) mg.h/L. On days 5-7 the values were: Cmax, 6.1 (4.0-10.4) mg/L; AUC0-2, 8.5 (0.8-16.8) mg.h/L, and by days 8-10 the values were: Cmax, 6.4 (3.3-12.5) mg/L; AUC0-2, 8.6 (0.8-23.1) mg.h/L. There was a statistically significant difference between Cmax pre- and Cmax two to three days post-chemotherapy (paired t-test, P = 0.05). These changes are similar to those previously reported with ciprofloxacin but less marked.
Collapse
Affiliation(s)
- N M Brown
- Department of Medical Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | | | | | | | |
Collapse
|
37
|
|
38
|
|
39
|
|
40
|
Cowling P, Rogers S, McMullin CM, White LO, Lovering AM, MacGowan AP, Reeves DS. The pharmacokinetics of lomefloxacin in elderly patients with urinary tract infection following daily dosing with 400 mg. J Antimicrob Chemother 1991; 28:101-7. [PMID: 1663107 DOI: 10.1093/jac/28.1.101] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Eleven elderly patients (mean age 83 years; range 75-90) with microbiologically proven urinary tract infections were given 400 mg lomefloxacin as a single daily dose for up to seven days. On the first and final day of treatment blood was taken at timed intervals and drug concentration-time curves plotted. Blood was also taken immediately before each of the other doses for assay of pre-dose concentrations. The mean (+/- S.D.) peak serum concentration of lomefloxacin on the first day was 4.8 mg/l (+/- 1.5) observed at a mean of 156 min (+/- 88) and on the final day was 6.3 mg/l (+/- 2.5) at a mean of 119 min (+/- 68). The mean serum half-life on the first day was 10.0 h (+/- 2.8) and on the final day 10.3 h (+/- 2.5). The daily pre-dose serum concentrations of lomefloxacin showed no accumulation of the drug. No serious adverse events were reported and all patients were cured although two had persistent pyuria. It is suggested that a once daily dose of 400 mg lomefloxacin is suitable for the elderly and that no dosage modification is needed in this patient group.
Collapse
Affiliation(s)
- P Cowling
- Department of Medical Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | | | | | | | |
Collapse
|
41
|
Johnson EJ, MacGowan AP, Potter MN, Stockley RJ, White LO, Slade RR, Reeves DS. Reduced absorption of oral ciprofloxacin after chemotherapy for haematological malignancy. J Antimicrob Chemother 1990; 25:837-42. [PMID: 2373666 DOI: 10.1093/jac/25.5.837] [Citation(s) in RCA: 24] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Six patients with newly diagnosed haematological malignancy were treated with ciprofloxacin 500 mg orally, as chemoprophylaxis during neutropenia. The mean serum ciprofloxacin concentrations, measured 1, 2, 3 and 4 h after dosage were reduced for up to ten days after the start of chemotherapy. The mean maximum serum concentration and AUC 0-4 h were reduced from 3.7 (95% confidence limits, 2.3-5.1) mg/l and 10.7 (6.2-15.2) mg/l.h pre-chemotherapy to 2.0 (1.4-2.6) mg/l and 5.7 (4.4-7.0) mg/l.h, 13 days after chemotherapy. Absorption of ciprofloxacin is reduced after cytotoxic chemotherapy, and this may have implications for the use of oral ciprofloxacin in this group of patients.
Collapse
Affiliation(s)
- E J Johnson
- Department of Microbiology, Southmead Hospital, Westbury-on-Trym, Bristol, UK
| | | | | | | | | | | | | |
Collapse
|
42
|
Lovering AM, White LO, Lewis DA, MacGowan AP, Routh KR, Pickin DM, Reeves DS. Pharmacokinetics of FCE 22101 in man following different modes of administration. J Antimicrob Chemother 1989; 23 Suppl C:179-95. [PMID: 2732141 DOI: 10.1093/jac/23.suppl_c.179] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
Twelve healthy volunteers received single iv doses of either 500 and 1000 mg or 750 and 1500 mg of the sodium salt of FCE 22101; in addition, five of the volunteers received a further dose of 2000 mg. In the second part of the study, 11 of the volunteers received 1000 mg doses of FCE 22101 in a four-way randomized fashion by iv bolus (1000 mg, with and without probenecid), im injection (1000 mg plus lignocaine) and a continuous infusion (280 mg/h) to steady state. All doses were well tolerated by the volunteers with no serious side effects and no significant haematological or biochemical changes following drug administration. Plasma and urine concentrations of FCE 22101, and in the cross-over study also its open ring metabolites P1 and P2, were determined by HPLC. Good linearity was observed between the peak plasma levels or AUC and the dose given. Plasma concentrations were fitted to a two-compartment model and the mean pharmacokinetic parameters determined after iv bolus were: Cmax 117 mg/l, T1/2 beta 36 min, Vss 181, AUC 2179 mg/min/l with urinary recoveries of FCE 22101 37%, P1 36% and P2 6%. With probenecid the values were Cmax 116 mg/l, T1/2 beta 47 min, Vss 141, AUC 4540 mg/min/l and urinary recoveries of FCE 22101 20%, P1 40% and P2 7%. Following im injection the mean values were Cmax 15 mg/l, Tmax 30 min, T1/2abs 14 min, T1/2 beta 61 min, AUC 2117 mg/min/l and urinary recoveries of FCE 22101 33%, P1 37% and P2 6%. At steady state during continuous infusion, mean values were Css 12.7 mg/l, Vss 131 and T1/2 beta after steady state was 22 min. Although urinary recoveries varied widely between volunteers there was a tendency towards consistency of recovery within individual volunteers. We conclude that FCE 22101 is a well tolerated penem with pharmacokinetic properties broadly similar to those of other penem and carbapenem antibiotics.
Collapse
Affiliation(s)
- A M Lovering
- Department of Medical Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | | | | | | | |
Collapse
|
43
|
Humphreys H, Lovering A, White LO, Williams EW. Flavobacterium meningosepticum infection, in a 32-day-old child on acute peritoneal dialysis, treated with ciprofloxacin. J Antimicrob Chemother 1989; 23:292-4. [PMID: 2496073 DOI: 10.1093/jac/23.2.292] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
Affiliation(s)
- H Humphreys
- Department of Microbiology, Bristol Royal Infirmary, UK
| | | | | | | |
Collapse
|
44
|
Abstract
Eight patients aged over 65 years (mean age 81 years), with microbiologically proven urinary tract infections were treated with 400 mg norfloxacin bd daily for six days. Blood samples were taken on day 1 and day 6 to give a concentration-time profile, and on each of the other days samples were obtained before the first dose of the day. Urine was collected throughout. The mean of the maximum serum concentration of norfloxacin after the first dose was 1.5 mg/l (range 1.1-1.8 mg/l) at a mean of 3.2 h (range 1-6 h). After the last dose the mean maximum concentration was 2.2 mg/l (range 1.6-3.7 h) at 3 h (range 1-4 h). The mean serum half life was 5 h (range 3.7-6.5 h) on day 1 and 5.3 h range (4.4-6.2 h) on day 6. Serum pre-dose norfloxacin levels showed no evidence of accumulation. Mean urinary concentrations varied between 95 and 288 mg/l from day 1 to day 6. No significant adverse reactions were noted. No alteration of norfloxacin dose is suggested in the aged with normal renal function.
Collapse
Affiliation(s)
- A P MacGowan
- Department of Medical Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | | | |
Collapse
|
45
|
White LO, Edwards R, Holt HA, Lovering AM, Finch RG, Reeves DS. The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline. J Antimicrob Chemother 1988; 22:739-45. [PMID: 3061999 DOI: 10.1093/jac/22.5.739] [Citation(s) in RCA: 31] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/03/2023] Open
Abstract
Solutions of vancomycin in phosphate-buffered saline, peritoneal dialysis effluent fluid and human serum were incubated at 37 degrees C for ten days and sampled at daily intervals. The samples were assayed for vancomycin content by a microbiological assay, HPLC and polarisation fluoroimmunoassay (Abbott TDX). The results obtained by HPLC and microbiological assay agreed well and indicated approximately 50% loss over ten days in serum and buffered saline and over 70% loss in dialysate. TDX results indicated losses of only 20% and 40%, respectively. Degradation products were prepared from vancomycin by acid hydrolysis and purified by HPLC. These purified products were shown to cross-react in the TDX assay. It is suggested that the TDX assay becomes non-specific in the presence of vancomycin breakdown products and thus overestimates true vancomycin concentrations.
Collapse
Affiliation(s)
- L O White
- Department of Medical Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | | | | | |
Collapse
|
46
|
White LO, MacGowan AP, Mackay IG, Reeves DS. The pharmacokinetics of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide in haemodialysis patients with end-stage renal failure. J Antimicrob Chemother 1988; 22 Suppl C:65-72. [PMID: 3182464 DOI: 10.1093/jac/22.supplement_c.65] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Abstract
Six patients with end-stage chronic renal failure undergoing haemodialysis were given ofloxacin (600 mg) orally and blood samples were taken at intervals up to 32 h. In four patients samples were also taken before and after haemodialysis. Serum concentrations of ofloxacin, desmethyl ofloxacin and ofloxacin N-oxide were measured by HPLC. The drug was well tolerated. Mean pharmacokinetic parameters for ofloxacin were Cmax 5.5 h (S.D. 1.97 h), Tmax 3.9 h (S.D. 3.25 h), T1/2 28 h (S.D. 17.37 h), AUC0-24 83.1 mg/1 h (S.D. 32.69 mg/l h). The desmethyl metabolite was produced in all patients but only half produced N-oxide. Cmax values were 0.21 mg/l (desmethyl) and 0.37 mg/l (N-oxide). Ofloxacin and desmethyl ofloxacin were variably and only slightly removed by haemodialysis whilst ofloxacin N-oxide was not removed at all. These results confirm that dosage reduction of ofloxacin is required in haemodialysis patients. Therapeutic drug monitoring by HPLC is recommended because of the observed variability in absorption and plasma half life.
Collapse
Affiliation(s)
- L O White
- Department of Microbiology, Southmead Hospital, Bristol, UK
| | | | | | | |
Collapse
|
47
|
Desai KM, Abrams PH, White LO. A double-blind comparative trial of short-term orally administered enoxacin in the prevention of urinary infection after elective transurethral prostatectomy: a clinical and pharmacokinetic study. J Urol 1988; 139:1232-4. [PMID: 2453683 DOI: 10.1016/s0022-5347(17)42875-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
A double-blind randomized comparative study was done to investigate the efficacy of enoxacin in the prevention of urinary infection after elective transurethral prostatectomy, as well as its ability to penetrate the prostate. A total of 40 patients received 200 mg. enoxacin and 40 received a placebo, given orally the night before the operation, 2 to 4 hours preoperatively and every 12 hours postoperatively for 36 hours. Urine samples for bacterial culture were obtained within 1 week preoperatively, at operation and at 48 hours, 5 days, and 2 and 6 weeks postoperatively. Samples of the serum and prostate were taken at operation and assayed for enoxacin levels. Of the placebo patients 15 had a urinary infection postoperatively (38 per cent) compared to 3 enoxacin patients (8 per cent) (p less than 0.01). Enoxacin penetrated well into prostatic tissue; the mean levels in tissue and serum were 3.1 +/- 1.8 mg. per kg. (standard deviation) and 1.26 +/- 0.48 mg. per l., respectively, with a mean tissue-to-serum ratio of 2.53 +/- 1.8.
Collapse
Affiliation(s)
- K M Desai
- Department of Urology, Southmead Hospital, Bristol, United Kingdom
| | | | | |
Collapse
|
48
|
|
49
|
|
50
|
Abstract
An aminoglycoside-acetylating enzyme produced by a strain of Escherichia coli with an unusual resistance phenotype was characterized. This enzyme was found to mono-acetylate apramycin, butirosin, lividomycin and paromomycin and diacetylate ribostamycin and neomycin to give reaction products which were distinguishable by HPLC analysis from those of AAC(2'), AAC(3) and AAC(6') enzymes. The enzyme, however, was not found to acetylate amikacin, fortimicin, geneticin, gentamicin, kanamycin A, netilmicin or tobramycin. The reaction product from the action of this enzyme on apramycin was purified and identified by nuclear magnetic resonance studies as 1-N-acetyl apramycin. The second site at which ribostamycin and neomycin B were modified by this enzyme was not determined but is postulated as the 6'-amino group. It is proposed that this enzyme be named AAC(1).
Collapse
Affiliation(s)
- A M Lovering
- Department of Medical Microbiology, Southmead Hospital, Bristol, U.K
| | | | | |
Collapse
|